Managers / Q3 2022 · view latest →
Price Jennifer C.
CIK 0001930102
Summary
Price Jennifer C. reported $485M in U.S.-listed holdings across 112 positions for Q3 2022.
Its largest position, Bunge Limited, represents 6.5% of the portfolio.
Compared with Q2 2022, the fund opened 2 new positions and exited 13.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 77.9% · $377M
- Other · 19.1% · $92M
- REIT · 1.1% · $5M
- MLP · 0.9% · $4M
- Ltd Part · 0.6% · $3M
- Other · 0.5% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Chord Energy Corp | NEW | +32.5K | 32.5K | +$4M | $4M |
| CRBGCorebridge Financial Inc | NEW | +150.0K | 150.0K | +$3M | $3M |
| GLDDGreat Lakes Dredge & Dock | ADDED | +640.0K | 690.0K | +$5M | $5M |
| GOOGLAlphabet Inc. | ADDED | +21.8K | 24.0K | −$2M | $2M |
| SONOSonos, Inc. | ADDED | +205.0K | 260.0K | +$3M | $4M |
| LABStandard Biotools Inc. | ADDED | +609.2K | 854.2K | +$548,000 | $940,000 |
| EQRx, Inc. | SOLD OUT | −895.6K | 0 | −$4M | $0 |
| CHRDChord Energy Corp | SOLD OUT | −32.5K | 0 | −$4M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $75M | 31 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $90M | 30 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $86M | 37 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $106M | 40 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $150M | 50 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $173M | 50 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $291M | 72 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $314M | 78 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $418M | 88 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $485M | 112 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $585M | 125 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- MFP INVESTORS LLC028-05359
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.